Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder

Abstract Repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) is associated with changes in brain functional connectivity (FC). These changes may be related to the mechanism of action of rTMS and explain the variability in clinical outcome. We examined cha...

Full description

Saved in:
Bibliographic Details
Published inCerebral cortex (New York, N.Y. 1991) Vol. 29; no. 12; pp. 4958 - 4967
Main Authors Corlier, Juliana, Wilson, Andrew, Hunter, Aimee M, Vince-Cruz, Nikita, Krantz, David, Levitt, Jennifer, Minzenberg, Michael J, Ginder, Nathaniel, Cook, Ian A, Leuchter, Andrew F
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 17.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) is associated with changes in brain functional connectivity (FC). These changes may be related to the mechanism of action of rTMS and explain the variability in clinical outcome. We examined changes in electroencephalographic FC during the first rTMS treatment in 109 subjects treated with 10 Hz stimulation to left dorsolateral prefrontal cortex. All subjects subsequently received 30 treatments and clinical response was defined as ≥40% improvement in the inventory of depressive symptomatology-30 SR score at treatment 30. Connectivity change was assessed with coherence, envelope correlation, and a novel measure, alpha spectral correlation (αSC). Machine learning was used to develop predictive models of outcome for each connectivity measure, which were compared with prediction based upon early clinical improvement. Significant connectivity changes were associated with clinical outcome (P < 0.001). Machine learning models based on αSC yielded the most accurate prediction (area under the curve, AUC = 0.83), and performance improved when combined with early clinical improvement measures (AUC = 0.91). The initial rTMS treatment session produced robust changes in FC, which were significant predictors of clinical outcome of a full course of treatment for MDD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1047-3211
1460-2199
1460-2199
DOI:10.1093/cercor/bhz035